The higher education expenditure on R&D in medical and health sciences in Japan shows steady projected growth from 2024 to 2028. The expenditure begins at 7.27 billion USD PPP in 2024, increasing annually to reach 7.67 billion USD PPP in 2028. This reflects a consistent upward trend, surpassing the actual value recorded in 2023.

Year-on-year, there are small percentage increases: approximately 1.38% in 2025, 1.49% in 2026, 1.34% in 2027, and 1.19% in 2028. Over the forecasted period, the compound annual growth rate (CAGR) is approximately 1.36%.

Future trends to watch for include:

Increased emphasis on medical innovation and technology integration driven by societal health needs.
Potential shifts in government policy and funding priorities affecting research budgets.
International collaborations enhancing research capacity and results.